Self Monitoring Blood Glucose Devices Market Scope And Analysis

Report Code : TIPRE00008684
Category : Life Sciences

No. of Pages : 150

Buy Now

Self-Monitoring Blood Glucose Devices (SMBGDs) Market Scope and Analysis Report by 2031

Buy Now

Self-Monitoring Blood Glucose Devices (SMBGDs) Market Report Scope

Report Attribute	Details
Market size in 2023	US$ XX Million
Market Size by 2031	US$ XX Million
Global CAGR (2023 - 2031)	XX%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Type Blood Glucose Meters Lancets Test Strips Other Product Types By Application Type 1 Diabetes Type 2 Diabetes and Gestational Diabetes By End User Hospitals & Clinics Diagnostic Centers Home Care Settings Other End Users
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories Limited ALLMEDICUS ARKRAY Inc Ascensia Diabetes Care Holdings AG B Braun Melsungen AG Bionime Corporation Dexcom Inc F Hoffmann La Roche Ltd Johnson Johnson Services Inc

Industry Developments and Future Opportunities:

The self-monitoring blood glucose devices market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players \

operating in the market are listed below:

In March 2023, Astellas Pharma I 1`1` bvp. pp, "TempoSmart," and a prefilled insulin pen, "Tempo Pen" that work together to deliver personalized guidance for adults suffering from diabetes. The app was developed in partnership with Welldoc company and is a private label iteration of the company's "BlueStar," a diabetes management app customized to receive insulin dose-related data from the Tempo Smart Button.

Competitive Landscape and Key Companies:

B. Braun SE, F. Hoffmann-La-Roche, LifeScan Inc., Medtronic, Abbott, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare, and Terumo Corp are among the prominent companies profiled in the self-monitoring blood glucose devices market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.